Results 251 to 260 of about 377,127 (288)
Some of the next articles are maybe not open access.

Helicobacter Pylori

Current Treatment Options in Gastroenterology, 1999
All infected patients with a peptic ulcer should be treated for H. pylori. The role of treating H. pylori in patients with undiagnosed dyspepsia or non-ulcer dyspepsia, those taking nonsteroidal anti-inflammatory medications, or with a family history of gastric cancer remains controversial.
openaire   +2 more sources

Review: Epidemiology of Helicobacter pylori infection

Helicobacter, 2019
This review summarizes recent publications on the epidemiology of Helicobacter pylori. Two major systemic analyses, from Malaysia and Ethiopia, were published. The Brazilian Consensus Conference has stated that H pylori infection is an infectious disease
M. Leja   +3 more
semanticscholar   +1 more source

Nationwide antibiotic resistance mapping of Helicobacter pylori in Korea: A prospective multicenter study

Helicobacter, 2019
The eradication rates for Helicobacter pylori have decreased in Korea although the prevalence of this bacterium has also decreased. Antibiotic resistance is likely to be a crucial factor in H.
Jeong Hoon Lee   +21 more
semanticscholar   +1 more source

The eradication of Helicobacter pylori restores rather than disturbs the gastrointestinal microbiota in asymptomatic young adults

Helicobacter, 2019
The eradication of Helicobacter pylori (H pylori) has been suggested to reduce the risk of gastric cancer, but its impact on the gut microbiota has attracted public attention.
Cong He   +7 more
semanticscholar   +1 more source

Screening for Helicobacter pylori

The Lancet, 1991
Screening for Helicobacter ...
Vaira D.   +4 more
openaire   +4 more sources

Seroconversion for Helicobacter pylori

The Lancet, 1993
The prevalence of Helicobacter pylori antibodies increases with age, but it is unknown whether this is due to a constant rate of infection in different age groups, or whether most infection occurs in childhood. Follow-up data on infection rates and the course of infection in an untreated population are scarce.
Kuipers, E. J.   +7 more
openaire   +4 more sources

Bismuth supplements as the first‐line regimen for Helicobacter pylori eradication therapy: Systemic review and meta‐analysis

Helicobacter, 2019
An increase in the use of antibiotics leads to increased antibiotic resistance of Helicobacter pylori (H pylori). Consequently, it has been considered that the first‐line standard regimen should be changed.
S. Ko, Y. Kim, W. Chung, Seung Jae Lee
semanticscholar   +1 more source

Helicobacter pylori

2015
This chapter discusses Helicobacter pylori, a gram-negative spiral-shaped bacteria that infects more than 50% of humans globally. H. pylori infection is a serious, chronic, transmissible infectious disease that causes progressive, destructive inflammation of the stomach and is etiologically related to a number of important diseases, including gastric ...
David Y. Graham, Emiko Rimbara
openaire   +1 more source

Transmission of Helicobacter pylori

Minerva Gastroenterologica e Dietologica, 2018
The exact modes and routes of transmission of Helicobacter pylori (H. pylori) infection remain unproven. Studies showed that H. pylori bacteria can spread directly from one person to the other, or indirectly from an infected person to the environment. Presently, interpersonal pathways are more probable than environmental exposure routes.
Mladenova, Irena, Durazzo, Marilena
openaire   +4 more sources

Primary and secondary antibiotic resistance of Helicobacter pylori in Korea from 2003 to 2018

Helicobacter, 2019
Antimicrobial resistance of Helicobacter pylori (H pylori) affects the efficacy of eradication therapy. The aim of this study was to estimate the prevalence of primary and secondary resistance of H pylori isolates to antibiotics in Korea.
J. Y. Lee   +5 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy